Open AccessNephrogenic Systemic Fibrosis Risk After Liver Magnetic Resonance Imaging With Gadoxetate Disodium in Patients With Moderate to Severe Renal Impairment
Author(s) -
Thomas C. Lauenstein,
Francisco Ramírez-Garrido,
Young Hoon Kim,
Sung Eun Rha,
Jens Ricke,
Sith Phongkitkarun,
Joachim Boettcher,
Rajan T. Gupta,
Pornpim Korpraphong,
Wiwatana Tanomkiat,
Julia Furtner,
Peter S. Liu,
Maren Henry,
Jan Endrikat
Publication year - 2015
Publication title -
investigative radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.33
H-Index - 114
eISSN - 1536-0210
pISSN - 0020-9996
DOI - 10.1097/rli.0000000000000145
Subject(s) - medicine , magnetic resonance imaging , nephrogenic systemic fibrosis , prospective cohort study , liver disease , radiology , urology
The objective of this study was to assess the risk of gadoxetate disodium in liver imaging for the development of nephrogenic systemic fibrosis (NSF) in patients with moderate to severe renal impairment.